Skip to main content
Year archive

Orexo — 2013 filings

All 75 regulatory filings released by Orexo (ORX) in 2013, sourced directly from the official regulator.

75 Filings
2013 Period
2013 filings (75)
Filing Released Lang
Orexo justerar förväntat rörelseresultat för fjärde kvartalet 2013
Earnings Release Q4 2013
2013-12-20 Swedish
Orexo adjusts EBIT expectations for Q4, 2013
Earnings Release Q4 2013
2013-12-20 English
Brev till aktieägare i Orexo från ordförande Martin Nicklasson
Management Reports
2013-12-19 Swedish
Letter to Orexo shareholders from Chairman Martin Nicklasson
Legal Proceedings Report
2013-12-19 English
Orexo meddelar att Abstral® lanseras i Japan
Regulatory Filings
2013-12-12 Swedish
Orexo announces the launch of Abstral® in Japan
Regulatory Filings
2013-12-12 English
Antal aktier och röster i Orexo
Declaration of Voting Results & Voting Rights Announcements
2013-11-29 Swedish
Number of shares and votes in Orexo
Declaration of Voting Results & Voting Rights Announcements
2013-11-29 English
Handel med Orexo AB ADR:s påbörjas på OTCQX i USA
Regulatory Filings
2013-11-13 Swedish
Orexo AB ADRs commence trading on OTCQX in the U.S.
Regulatory Filings
2013-11-13 English
Antal aktier och röster i Orexo
Declaration of Voting Results & Voting Rights Announcements
2013-10-31 Swedish
Number of shares and votes in Orexo
Declaration of Voting Results & Voting Rights Announcements
2013-10-31 English
Interim / Quarterly Report 2013
Interim / Quarterly Report 9M 2013
2013-10-23 Swedish
Interim / Quarterly Report 2013
Interim / Quarterly Report 9M 2013
2013-10-23 English
Orexo utser valberedning och offentliggör finansiell kalender 2013/2014
AGM Information
2013-10-15 Swedish
Orexo appoints Nomination Committee and publishes financial calendar 2013/2014
AGM Information
2013-10-15 English
Antal aktier och röster i Orexo
Share Issue/Capital Change
2013-09-30 Swedish
Number of shares and votes in Orexo
Share Issue/Capital Change
2013-09-30 English
Orexo får godkännande för Abstral® i Japan
Regulatory Filings
2013-09-20 Swedish
Orexo announces the approval of Abstral® in Japan
Regulatory Filings
2013-09-20 English
Orexo AB implementerar ADR-program i USA samtidigt med den kommersiella lanseringen av Zubsolv®
Delisting Announcement
2013-09-16 Swedish
Orexo AB announces full implementation of its ADR Program in the United States concurrently with its commercial launch of Zubsolv®
Regulatory Filings
2013-09-16 English
Orexo provides update on reimbursement and launch preparations for Zubsolv®
Regulatory Filings
2013-09-05 English
Orexo ger en uppdatering om subvention och förberedelser inför lanseringen av Zubsolv®
Earnings Release FY 2013
2013-09-05 Swedish
Number of shares and votes in Orexo
Declaration of Voting Results & Voting Rights Announcements
2013-08-30 English
Antal aktier och röster i Orexo
Declaration of Voting Results & Voting Rights Announcements
2013-08-30 Swedish
Major Shareholding Notification 2013
Major Shareholding Notification
2013-08-29 English
Orexo reports successful completion of OX51 phase II dose-finding study in prevention of procedure-induced pain
Legal Proceedings Report
2013-08-28 English
Orexo meddelar att OX51 fas II-studie för förebyggande av smärta i samband med ingrepp avslutats
Regulatory Filings
2013-08-28 Swedish
Orexo AB konverterar konvertibellån från Novo A/S
Capital/Financing Update
2013-08-26 Swedish
Orexo AB converts convertible bonds subscribed for by Novo A/S
Capital/Financing Update
2013-08-26 English
First patient dosed in new study on long-term adherence to treatment of opioid dependence with Zubsolv®
Regulatory Filings
2013-08-07 English
Första patienten har påbörjat medicineringen i en ny klinisk studie syftande till att fastställa tidiga behandlingseffekter och acceptans för Zubsolv®
Regulatory Filings
2013-08-07 Swedish
Kommuniké från extra bolagsstämma i Orexo AB den 6 augusti 2013
AGM Information
2013-08-06 Swedish
Report from the extraordinary general meeting in Orexo AB, 6 August 2013
AGM Information
2013-08-06 English
Letter to shareholders from Chairman Martin Nicklasson
Legal Proceedings Report
2013-07-19 English
Aktieägarbrev från ordförande Martin Nicklasson
Regulatory Filings
2013-07-19 Swedish
Orexo appoints Henrik Juuel as new CFO
Board/Management Information
2013-07-15 English
Orexo utser Henrik Juuel till ny CFO
Board/Management Information
2013-07-15 Swedish
Interim / Quarterly Report 2013
Interim / Quarterly Report H1 2013
2013-07-12 Swedish
Interim / Quarterly Report 2013
Interim / Quarterly Report H1 2013
2013-07-12 English
Notice of Extraordinary General Meeting of Orexo
AGM Information
2013-07-04 English
Kallelse till extra bolagsstämma i Orexo
AGM Information
2013-07-04 Swedish
Antal aktier och röster i Orexo
Declaration of Voting Results & Voting Rights Announcements
2013-07-02 Swedish
Number of shares and votes in Orexo
Declaration of Voting Results & Voting Rights Announcements
2013-07-02 English
Orexo ingår kommersiellt partnerskap med Publicis Touchpoint Solutions för lanseringen av Zubsolv™ i USA
Regulatory Filings
2013-07-01 Swedish
Orexo Appoints Robert A. DeLuca as President of Orexo US Inc.
Board/Management Information
2013-07-01 English
First patient dosed in new phase III study targeted towards a future clinical indication expansion for Zubsolv
Regulatory Filings
2013-06-17 English
Första patienten behandlad i en ny fas III-studie med syfte att utvidga den kliniska användningen av Zubsolv
Regulatory Filings
2013-06-17 Swedish
Antal aktier och röster i Orexo
Share Issue/Capital Change
2013-05-31 Swedish
Number of shares and votes in Orexo
Share Issue/Capital Change
2013-05-31 English
Interim / Quarterly Report 2013
Interim / Quarterly Report Q1 2013
2013-04-26 Swedish
Interim / Quarterly Report 2013
Interim / Quarterly Report Q1 2013
2013-04-26 English
Report from Orexo AB’s Annual General Meeting, 11 April 2013
AGM Information
2013-04-11 English
Kommuniké från Orexo AB:s årsstämma den 11 april 2013
AGM Information
2013-04-11 Swedish
Antal aktier och röster i Orexo
Declaration of Voting Results & Voting Rights Announcements
2013-03-28 Swedish
Number of shares and votes in Orexo
Declaration of Voting Results & Voting Rights Announcements
2013-03-28 English
Annual Report 2012
Annual Report FY 2012
2013-03-21 Swedish
Annual Report 2012
Annual Report FY 2012
2013-03-21 English
Orexo säljer Abstral® i USA till Galena Biopharma, Inc.
M&A Activity
2013-03-18 Swedish
Orexo sells Abstral® in the United States to Galena Biopharma, Inc.
Earnings Release FY 2013
2013-03-18 English
Notice of Annual General Meeting of Orexo
AGM Information
2013-03-12 English
Kallelse till årsstämma i Orexo
AGM Information
2013-03-12 Swedish
Antal aktier och röster i Orexo
Declaration of Voting Results & Voting Rights Announcements
2013-02-28 Swedish
Number of shares and votes in Orexo
Declaration of Voting Results & Voting Rights Announcements
2013-02-28 English
Avtal med Novartis kring GERD-programmet OX17 avslutas
Legal Proceedings Report
2013-02-25 Swedish
Agreement with Novartis on OX17 for GERD terminated
Regulatory Filings
2013-02-25 English
Orexo strengthens the commercial leadership structure and appoints Nikolaj Sørensen as new CEO and Martin Nicklasson as Executive Chairman
Board/Management Information
2013-02-05 English
Orexo stärker den kommersiella ledningsstrukturen och utser Nikolaj Sørensen till ny VD och Martin Nicklasson till arbetande styrelseordförande
Board/Management Information
2013-02-05 Swedish
Number of shares and votes in Orexo
Declaration of Voting Results & Voting Rights Announcements
2013-01-31 English
Antal aktier och röster i Orexo
Declaration of Voting Results & Voting Rights Announcements
2013-01-31 Swedish
Interim / Quarterly Report 2012
Interim / Quarterly Report FY 2012
2013-01-31 Swedish
Interim / Quarterly Report 2012
Interim / Quarterly Report FY 2012
2013-01-31 English
Orexo enters research agreement with AstraZeneca for respiratory disease program
Regulatory Filings
2013-01-25 English
Orexo ingår forskningsavtal med AstraZeneca inom området luftvägssjukdomar
Regulatory Filings
2013-01-25 Swedish